US Patent 11040109 Blood coagulation protein conjugates
Patent 11040109 was granted and assigned to Takeda Pharmaceutical Company on June, 2021 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
June 20, 2019
Date of Patent
June 22, 2021
Patent Application Number
16447134
Patent Citations
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11040109 Blood coagulation protein conjugates
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.